KBI1393
KRIBIOLISA™ Inebilizumab (UPLIZNA) ELISA
Krishgen Biosystems
DESCRIPTION
Enzyme Immunoassay for the quantitative determination of Inebilizumab in serum and plasma. Lead Time 3 - 4 weeks.
DETAILS
- Usage: For Research Use Only
- Category: ELISA
- Lead Time: 3 - 4 weeks
- Assay Range: 0 - 640 ng/ml
- Sample Type: Serum and Plasma
- Sensitivity: 7.5 ng/ml
- Shipping Temp: 2 - 8 degrees C
- Detection Method: Colorimetric, 450nm
- Species Reactivity: Human